DTIL

Precision BioSciences, Inc. Common Stock
Data: 2026-01-30
$3.96
Price
-1.88%
Change
$8.82
52W High
$3.7484
52W Low

Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.

Quick Stats
Jan 30, 2026

48.4

AI Score

HOLD

1.02

Volume Ratio

Next Earnings

12

+ve Days (30d)

17

-ve Days (30d)

DTIL Stock Summary

Last updated Jan 30, 2026

DTIL is currently trading at $3.96, positioned below its 200-day moving average of $5.06, suggesting bearish momentum. The stock has a 52-week range of $3.7484 to $8.82.

Technical Analysis: The 50-day moving average stands at $4.5, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 41.268, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.145, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates DTIL at 48.4/100 with a HOLD recommendation.

DTIL (Precision BioSciences, Inc. Common Stock) Indicators

Last updated Jan 30, 2026

Indicator Value
RSI(14) 41.268
CMF (20) 0.145
ROC (10) 1.538
ADX (14) 21.288
Indicator Value
MACD (12,26,9) -0.174
AROONOSC (14) 57.143
WILLAMS %R (14) -75.441
MFI (14) 59.451
DTIL Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

DTIL Price vs Max Options Open Interest
DTIL Max Change In Options Open Interest

DTIL Options - Sort by Max open Interest (near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

DTIL Daily Out of Money Options - Sort by Max open Interest (near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

DTIL Daily In the Money Options - Sort by Max open Interest (near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

DTIL Most Active Options by Volume(near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Precision BioSciences, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

DTIL Moving Averages Analysis

DTIL (Precision BioSciences, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Jan 30, 2026

Days MA
10 4.07
20 4.08
30 4.18
50 4.5
100 5.24
200 5.06

DTIL Fundamental Analysis

P/E (Forward) 11.7786
P/E (Trailing) --
Market Cap ($) 95.3 million
Earnings/Share ($) -8.89
Net Proft Margin (%) 0
Dividend/Share ($) --
EPS Estimate Current Year ($) -6.1633
EPS Estimate Next Year ($) -3.11
WallStreet Target Price ($) 32.5
Most Recent Quarter